...
首页> 外文期刊>International journal of molecular medicine >Electroacupuncture promotes chondrocyte proliferation via accelerated G1S transition in the cell cycle
【24h】

Electroacupuncture promotes chondrocyte proliferation via accelerated G1S transition in the cell cycle

机译:电针通过加速细胞周期中的G1S过渡来促进软骨细胞增殖

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to investigate the effects of electroacupuncture (EA) on the proliferation of chondrocytes and the molecular mechanism(s) involved. Passage 2 chondrocytes were randomly divided into four groups and treated with EA or nocodazole. After treatment, cell proliferation was determined using an MTT assay and DNA staining followed by FACS. The mRNA expression levels of cyclin D1, cyclin-dependent kinase (CDK)4, CDK6, phosphorylated retinoblastoma (pRb) and P16 were detected by RT-PCR, and the protein levels of cyclin D1, CDK4, CDK6, pRb and P16 were detected by western blotting. EA treatment significantly increased cell viability in a time-dependent manner and decreased the number of G0/G1 and G2/M phase chondrocytes and increased the number of S phase cells. The mRNA and protein levels of cyclin D1, CDK4, CDK6, (p)Rb and P16 consistently demonstrated a reverse trend with the levels in the chondrocytes treated with nocodazole. The expression levels of cyclin D1, CDK4, CDK6 and Rb were higher in chondrocytes receiving EA treatment when compared to levels in the untreated cells while expression of P16 was lower. In conclusion, EA treatment promotes chondrocyte proliferation via promotion of G1/S checkpoint transition in the cell cycle dependent on the activity of the P16-cyclin D1-CDK4/6-pRb pathway and this may, in part, explain its clinical effect in the treatment of osteoarthritis.
机译:本研究的目的是研究电针(EA)对软骨细胞增殖的影响及其涉及的分子机制。将第2代软骨细胞随机分为四组,并用EA或诺考达唑处理。处理后,使用MTT测定法和DNA染色,然后进行FACS测定细胞增殖。通过RT-PCR检测细胞周期蛋白D1,细胞周期蛋白依赖性激酶(CDK)4,CDK6,磷酸化视网膜母细胞瘤(pRb)和P16的mRNA表达水平,并检测细胞周期蛋白D1,CDK4,CDK6,pRb和P16的蛋白水平。通过蛋白质印迹。 EA处理以时间依赖性方式显着增加了细胞活力,并减少了G0 / G1和G2 / M期软骨细胞的数量,并增加了S期细胞的数量。细胞周期蛋白D1,CDK4,CDK6,(p)Rb和P16的mRNA和蛋白质水平始终显示出与诺考达唑处理的软骨细胞中的水平相反的趋势。与未经处理的细胞相比,接受EA处理的软骨细胞中细胞周期蛋白D1,CDK4,CDK6和Rb的表达水平较高,而P16的表达较低。总而言之,EA治疗通过促进细胞周期中G1 / S检查点的转变来促进软骨细胞增殖,这取决于P16-cyclin D1-CDK4 / 6-pRb途径的活性,这可以部分解释其在肝癌中的临床作用。骨关节炎的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号